Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The basal ganglia and cerebral cortex together contain an immense diversity of **neuronal cells**, primarily including excitatory glutamatergic neurons (such as pyramidal cells in the cortex) and inhibitory GABAergic neurons (such as medium spiny neurons in the striatum and various interneurons). The **basal ganglia** are deeply located subcortical nuclei including the striatum (caudate nucleus, putamen, nucleus accumbens), globus pallidus, subthalamic nucleus, and substantia nigra, which intricately modulate voluntary movement, procedural learning, emotion, and reward[1][2][3][4][5][6]. The **cerebral cortex** is the brain’s outer layer, central for perception, thought, voluntary action, and complex behavior. Both structures are functionally interdependent, linked by extensive neural circuits for movement control and higher cognitive processes. Importantly, the description "neuronal cells in basal ganglia and cortex" is not a recognized molecular target, but refers to neural populations and anatomical regions. Aberrant function or degeneration of neuronal cells in these regions underlies numerous neurologic and psychiatric diseases, such as Parkinson’s disease, Huntington’s disease, dystonia, and addiction[4][5][6]. Therapies often target neurotransmitter systems modulating these neurons, most notably the dopaminergic system in basal ganglia disorders.
modulation of dopaminergic or cholinergic neurotransmission, GABAergic modulation, glutamatergic modulation, neuromodulation via deep brain stimulation
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neuronal cells in basal ganglia and cortex.